Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term

Paola Ghione, MD, Peter Cordeiro, MD, Venkatraman Seshan, PhD, Natasha Galasso, Nivetha Ganesan, MPH, Qunying Hu, Ahmet Dogan, MD PhD, Steven M. Horwitz, MD

Blood (2019) 134 (Supplement_1): 2842.

https://doi.org/10.1182/blood-2019-122572

Published: 2019

Journal Articles

Good Care and Long-Term Follow-up in Young Hemophiliacs

Zeynep Iscan, MD, Basak Koc, MD, Onder Kilicoglu, Prof, Ata Atalar, Prof, Omer Taser, Prof, Gulten Cetik, Bulent Zulfikar, Prof

Blood (2018) 132 (Supplement 1): 5028.

https://doi.org/10.1182/blood-2018-99-117936

Published: 2018

Journal Articles

Multi-Center Clinical Trial of CAR T Cells in Pediatric/Young Adult Patients with Relapsed B-Cell ALL

Blood (2015) 126 (23): 2533.

https://doi.org/10.1182/blood.V126.23.2533.2533

Published: 2015

Journal Articles

Iliopsoas Hemorrhage in Pediatric Patients with Hemophilia, Experience from One Centre

Emine Türkkan, Didem Yalcin Atay, Suheyla Ocak, Gul Nihal Ozdemir, MD

Blood (2015) 126 (23): 4571.

https://doi.org/10.1182/blood.V126.23.4571.4571

Published: 2015

Journal Articles

Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL

Kevin J. Curran, MD, Isabelle Riviere, PhD, Rachel Kobos, MD, Nancy A. Kernan, MD, Farid Boulad, MD, Susan E. Prockop, MD, Andromachi Scaradavou, MD, Thomas M. Renaud, MD, Neerav Shukla, MD, Peter G Steinherz, MD, Jae H Park, MD, Craig S. Sauter, MD, Richard J O'Reilly, MD, Michel Sadelain, MD PhD, Renier J. Brentjens, MD PhD

Blood (2014) 124 (21): 3716.

https://doi.org/10.1182/blood.V124.21.3716.3716

Published: 2014

Journal Articles

Platelet Functional and Morphological Abnormalities In a Case Of Arthrogryposis, Renal Dysfunction and Cholestasis (ARC) Syndrome With a Novel Genetic Profile

Lesleigh S Abbott, MD, Ling Li, MD, Hilary Christensen, Fred Pluthero, PhD, Denisa Urban, Yigal Dror, MD, Walter H. Kahr, MD, PhD

Blood (2013) 122 (21): 3538.

https://doi.org/10.1182/blood.V122.21.3538.3538

Published: 2013

Journal Articles

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Marie Y. Detrait, MD, Roberto Crocchiolo, MD PhD, Stephane Vigouroux, MD, Jacques-Olivier Bay, MD, PhD, Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Stéphane Morisset, Stat., Reza Tabrizi, MD, Nicole Raus, Regis Peffault de la Tour, Gérard Socié, MD PhD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, MD PhD, Noel Milpied, MD, Didier Blaise, MD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 1947.

https://doi.org/10.1182/blood.V120.21.1947.1947

Published: 2012

Journal Articles

Joint Disease and the Potential for Improved Joint Health in Inhibitor Patients Who Have a Good Response to aPCC Prophylaxis: Data From the Profeiba Study

Cindy A. Leissinger, MD, Alessandro Gringeri, MD, Leonard A. Valentino, MD, Paolo A Cortesi, MSc

Blood (2012) 120 (21): 3374.

https://doi.org/10.1182/blood.V120.21.3374.3374

Published: 2012

Journal Articles

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

Yoshihiro Inamoto, MD, Barry Storer, PhD, Effie W. Petersdorf, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD, MPH, Lee Nelson, MD, Brenda M. Sandmaier, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD

Blood (2011) 118 (21): 322.

https://doi.org/10.1182/blood.V118.21.322.322

Published: 2011

Journal Articles

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Louis Terriou, Leonardo Magro, Eva De Berranger, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 2329.

https://doi.org/10.1182/blood.V116.21.2329.2329

Published: 2010

Journal Articles

Despite Tolerance of Imatinib Prior to Transplant, Imatinib Induces Prolonged Exanthematous Pustulosis in a Patient with Sclerodermatous Graft-Versus-Host Disease: A Case Report.

Michael Bishara, B.Sc, Caroline Hamm, MD

Blood (2009) 114 (22): 4670.

https://doi.org/10.1182/blood.V114.22.4670.4670

Published: 2009

Journal Articles

First Use of Allogeneic Stem Cells in the Treatment of Recessive Dystrophic Epidermolysis Bullosa: Demonstration of Biochemical and Clinical Improvement.

John E. Wagner, MD, Akemi Ishida-Yamamoto, Ph.D., John A McGrath, Ph.D., Maria Hordinsky, M.D., Douglas R Keene, B.S., Mark Osborn, B.S., Troy Lund, MD, PhD, Michelle Dolan, Bruce R. Blazar, MD, Jakub Tolar, MD, PhD

Blood (2009) 114 (22): 660.

https://doi.org/10.1182/blood.V114.22.660.660

Published: 2009

Journal Articles

Pentostatin in Steroid-Refractory Chronic Graft-Versus-Host Disease.

Javier Bolanos-Meade, MD, David Jacobsohn, MD, Viki Anders, CRNP, Megan Higman, MD, Allen Chen, MD, Michele Phelps, RN, Georgia B. Vogelsang, MD

Blood (2005) 106 (11): 1805.

https://doi.org/10.1182/blood.V106.11.1805.1805

Published: 2005

Journal Articles

Mixed Donor Chimerism and Low level alpha-L-iduronidase Expression May Be Adequate for Neurodevelopmental Protection in Hurler’s Syndrome.

Jennifer Conway, MD, Sarah Dyack, MD, Bruce N.A. Crooks, MB, ChB, Matthias Schmidt, MD, Conrad V. Fernandez, MD

Blood (2004) 104 (11): 5149.

https://doi.org/10.1182/blood.V104.11.5149.5149

Published: 2004

Journal Articles

Treatment of Chronic Graft-Versus-Host Disease With Clofazimine

Stephanie J. Lee, Scott A. Wegner, Carol J. McGarigle, Barbara E. Bierer, Joseph H. Antin

Blood (1997) 89 (7): 2298–2302.

https://doi.org/10.1182/blood.V89.7.2298

Published: 1997

NARROW

Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term

Good Care and Long-Term Follow-up in Young Hemophiliacs

Multi-Center Clinical Trial of CAR T Cells in Pediatric/Young Adult Patients with Relapsed B-Cell ALL

Iliopsoas Hemorrhage in Pediatric Patients with Hemophilia, Experience from One Centre

Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL

Platelet Functional and Morphological Abnormalities In a Case Of Arthrogryposis, Renal Dysfunction and Cholestasis (ARC) Syndrome With a Novel Genetic Profile

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Joint Disease and the Potential for Improved Joint Health in Inhibitor Patients Who Have a Good Response to aPCC Prophylaxis: Data From the Profeiba Study

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Despite Tolerance of Imatinib Prior to Transplant, Imatinib Induces Prolonged Exanthematous Pustulosis in a Patient with Sclerodermatous Graft-Versus-Host Disease: A Case Report.

First Use of Allogeneic Stem Cells in the Treatment of Recessive Dystrophic Epidermolysis Bullosa: Demonstration of Biochemical and Clinical Improvement.

Pentostatin in Steroid-Refractory Chronic Graft-Versus-Host Disease.

Mixed Donor Chimerism and Low level alpha-L-iduronidase Expression May Be Adequate for Neurodevelopmental Protection in Hurler’s Syndrome.

Treatment of Chronic Graft-Versus-Host Disease With Clofazimine

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only